Profiel
Henri B. Meier served as Chairman at HBM Partners AG starting in 2001.
He has been Chairman of the board at BioMedPartners AG since 2002.
Actieve functies van Henri B. Meier
| Bedrijven | Functie | Begin |
|---|---|---|
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Voorzitter | 01-08-2002 |
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Voorzitter | 06-03-2001 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners invests in companies located in Switzerland, Germany and neighboring Western Europe. The firm focuses on biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies. It participates in seed and early stage capital transactions. It also makes follow-on investments and acts a lead or co-lead investor. | Finance |
















